Business & Finance AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
U.K. pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.
By
· August 2, 2026 · 1 min read
This article was originally published by
CNBC Top News
and is republished here under license.
U.K. pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.
Related
Bank of America was among the prime brokers for the hedge fund, which is run by Leopold Aschenbrenner.…
By
· August 5, 2026 · 1 min read
Hiring at private companies slowed considerably in July, with most of the job growth coming health care.…
By
· August 5, 2026 · 1 min read
Abdul El-Sayed won the Michigan Democratic Senate primary, setting up a context with former Rep. Mike Rogers in the November…
By
· August 5, 2026 · 1 min read
Leave a Reply